Tizanidine
Product Images NDC 10544-863

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 10544-863). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 2mg 30ct (Label Tizanidine Tabs 2mg Bpi(10544 863 30) Apotex(60505 0251 3) Rev1)

Tizanidine Tablets, USP 2mg is a prescription drug containing 30 tablets, which must be stored at a controlled room temperature of 20°-25°C, with excursions permitted to 15°-30°C. It is packaged by Blenheim Pharmacal, Inc. and is used to treat muscle spasms caused by multiple sclerosis or spinal cord injuries. However, the text has some portions of unreadable or incomplete data.*

FDA Label Image

Structure (Tizanidine Imtb 01)

FDA Label Image

Graph (Tizanidine Imtb 02)

The text describes a figure showing the mean concentration of tizanidine over time for tablets and capsules that contain 2 x 4 mg doses of the drug under both fasting and fed conditions.*

FDA Label Image

Graph (Tizanidine Imtb 03)

This is a graph showing the mean change in muscle tone from baseline as measured by the Ashworth Scale with a 95% confidence interval in a single dose study. Negative Ashworth scores indicate an improvement in muscle tone from the baseline. The graph plots measurements taken at various hours post-dose.*

FDA Label Image

Graph (Tizanidine Imtb 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.